Functional Interaction of Amyloid-b Protein with Glial Toll-Like Receptors

淀粉样蛋白-b 与神经胶质 Toll 样受体的功能相互作用

基本信息

  • 批准号:
    8101760
  • 负责人:
  • 金额:
    $ 36.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a progressive neurodegenerative illness characterized by increasing dementia and ultimately death. Outstanding pathological features of AD include severe neuronal loss, accumulation of aggregated amyloid-¿ protein (A¿) in senile plaques and diffuse deposits, and neurofibrillary tau tangles. It is generally agreed that A¿ accumulation is a primary cause of AD yet several central questions remain. 1) What A¿ structure, aggregation state or species contributes to AD? and 2) How does the human immune system recognize and respond to A¿? Significant data demonstrate a sustained inflammatory response to A¿ in the AD brain which includes clustering of activated microglia and cytokines around A¿ deposits. Surprisingly, not all A¿ deposits provoke an inflammatory response suggesting that A¿ morphology/structure influences the response. These results raise several puzzling questions regarding the mechanism by which A¿ provokes an inflammatory response. Recent work has established that Toll-like receptors (TLRs) of the innate immune system mediate a proinflammatory response to aggregated A¿ suggesting that A¿ may possess structural elements that are similar to microbial macromolecules. The work in this proposal will utilize biophysical and cellular studies to establish a connection between A¿ morphology/structure and inflammation in primary murine microglia and astrocytes. The first research aim will investigate a variety of conditions that influence A¿ aggregation and structure and identify the conditions that result in the greatest A¿ proinflammatory activity (cytokine production) in primary microglia and astrocytes. A variety of biophysical techniques will be used to further understand the connection between A¿ structure and glial activation. The second research aim will utilize normal and transgenic knockout mice to identify and characterize complexes of TLRs, co-receptors, and protein cofactors that mediate A¿ bioactivity at the glial cell surface and inside the cell. Further understanding of A¿ activity may help explain why the human immune system is ineffective at controlling AD and provide a legitimate point of therapeutic mitigation. The scientific and biomedical importance of this project is its direct contribution to the understanding of Alzheimer's disease. The additional and equally important aspect of the project is the training opportunities that it provides for graduate and undergraduate researchers. The proposed research, which is a blend of cell biology, biochemistry, biophysics, nanoscience, and spectroscopy, will attract a diverse group of students to participate in interdisciplinary studies. This broad range of science will promote collaborative work and interactions between students and faculty from different departments. The primary mission of the project is to make a significant impact on Alzheimer's disease. An equally important objective is to prepare students for future interdisciplinary research by gaining knowledge in a multiple research areas, learning and refining laboratory skills, and interpreting, presenting, and publishing meaningful results. PUBLIC HEALTH RELEVANCE: Deaths from Alzheimer's disease (AD) have increased by 45% from 2000 to 2005, while deaths from heart disease, breast cancer, prostate cancer, and stroke have declined during the same time period. AD is projected to reach epic proportions by the middle of the 21st century overwhelming medical resources. The most appropriate way to develop treatments that will prevent or treat AD is to understand the underlying biochemical features of the disease. This proposal will examine molecular mechanisms linking AD and the human immune response potentially leading to therapies that utilize our own immune system to fight AD. Furthermore, the project will incorporate rigorous research training of students at all levels that will ultimately have a positive long-term impact on public health.
描述(由申请人提供):阿尔茨海默病(AD)是一种进行性神经退行性疾病,其特征在于痴呆增加并最终死亡。AD的突出病理学特征包括严重的神经元损失、聚集的淀粉样蛋白(A)在老年斑和弥漫性沉积物中的积累以及神经元性tau蛋白缠结。人们普遍认为A ²积累是AD的主要原因,但仍存在几个核心问题。1)什么样的A?结构、聚集状态或物种对AD有贡献?2)人类免疫系统如何识别和响应A?有意义的数据表明,AD脑中对A?的持续炎症反应包括A?沉积物周围活化的小胶质细胞和细胞因子的聚集。令人惊讶的是,并非所有的A?沉积物都引起炎症反应,这表明A?形态/结构影响反应。这些结果提出了几个令人困惑的问题,关于A?引起炎症反应的机制。最近的工作已经确定,先天免疫系统的Toll样受体(TLR)介导对聚集的A?的促炎反应,这表明A?可能具有与微生物大分子相似的结构元件。 本提案中的工作将利用生物物理学和细胞研究来建立原代小鼠小胶质细胞和星形胶质细胞中A?形态/结构与炎症之间的联系。第一个研究目标将调查影响A?聚集和结构的各种条件,并确定导致初级小胶质细胞和星形胶质细胞中最大A?促炎活性(细胞因子产生)的条件。各种生物物理技术将用于进一步了解A?结构和神经胶质激活之间的联系。第二个研究目标将利用正常和转基因敲除小鼠来鉴定和表征介导胶质细胞表面和细胞内A?生物活性的TLR、辅助受体和蛋白辅助因子的复合物。进一步了解A?活性可能有助于解释为什么人类免疫系统在控制AD方面是无效的,并提供治疗缓解的合理点。 该项目的科学和生物医学重要性在于其对阿尔茨海默病的理解的直接贡献。该项目的另一个同样重要的方面是为研究生和本科生研究人员提供培训机会。拟议的研究,这是一个细胞生物学,生物化学,生物物理学,纳米科学和光谱学的融合,将吸引学生参与跨学科研究的多元化群体。这一广泛的科学将促进来自不同部门的学生和教师之间的协作和互动。该项目的主要使命是对阿尔茨海默病产生重大影响。一个同样重要的目标是通过在多个研究领域获得知识,学习和完善实验室技能,以及解释,展示和出版有意义的结果,为学生未来的跨学科研究做好准备。 公共卫生关系:从2000年到2005年,阿尔茨海默病(AD)的死亡人数增加了45%,而心脏病、乳腺癌、前列腺癌和中风的死亡人数在同一时期有所下降。AD预计到21世纪中叶将达到史诗般的比例,压倒医疗资源。开发预防或治疗AD的治疗方法的最适当方法是了解该疾病的潜在生化特征。该提案将研究AD与人类免疫反应之间的分子机制,可能导致利用我们自己的免疫系统对抗AD的疗法。此外,该项目将对各级学生进行严格的研究培训,最终将对公共卫生产生积极的长期影响。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Aβ40 has a subtle effect on Aβ42 protofibril formation, but to a lesser degree than Aβ42 concentration, in Aβ42/Aβ40 mixtures.
  • DOI:
    10.1016/j.abb.2016.03.017
  • 发表时间:
    2016-05-01
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Terrill-Usery SE;Colvin BA;Davenport RE;Nichols MR
  • 通讯作者:
    Nichols MR
Amyloid-β(1-42) protofibrils formed in modified artificial cerebrospinal fluid bind and activate microglia.
  • DOI:
    10.1007/s11481-012-9424-6
  • 发表时间:
    2013-03
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Paranjape, Geeta S.;Terrill, Shana E.;Gouwens, Lisa K.;Ruck, Benjamin M.;Nichols, Michael R.
  • 通讯作者:
    Nichols, Michael R.
Amyloid-β42 protofibrils are internalized by microglia more extensively than monomers.
  • DOI:
    10.1016/j.brainres.2016.08.016
  • 发表时间:
    2016-10-01
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Gouwens LK;Makoni NJ;Rogers VA;Nichols MR
  • 通讯作者:
    Nichols MR
Amyloid-β(1-42) protofibrils stimulate a quantum of secreted IL-1β despite significant intracellular IL-1β accumulation in microglia.
尽管小胶质细胞中细胞内 IL-1β 积累显着,但淀粉样蛋白-β(1-42) 原纤维仍会刺激大量分泌的 IL-1β。
Disentangling aggregation-prone proteins: a new method for isolating α-synuclein species: An Editorial Highlight for "A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oli
解开易于聚集的蛋白质:一种分离 α-突触核蛋白种类的新方法:“一种简单、通用且强大的基于离心的过滤方案,用于分离和定量 α-突触核蛋白单体、oli
  • DOI:
    10.1111/jnc.14973
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Nichols,MichaelR
  • 通讯作者:
    Nichols,MichaelR
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael R. Nichols其他文献

Probing the amyloid-β(1–40) fibril environment with substituted tryptophan residues
  • DOI:
    10.1016/j.abb.2009.12.007
  • 发表时间:
    2010-02-15
  • 期刊:
  • 影响因子:
  • 作者:
    Jillienne C. Touchette;Laura L. Williams;Deepa Ajit;Fabio Gallazzi;Michael R. Nichols
  • 通讯作者:
    Michael R. Nichols
APP Regulates Microglial Phenotype in a Mouse Model of APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease Alzheimer's Disease
APP 调节阿尔茨海默病小鼠模型中的小胶质细胞表型 APP 调节阿尔茨海默病小鼠模型中的小胶质细胞表型
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    X. Gunjan;D. Manocha;A. Floden;XKeiko Rausch;XJoshua A. Kulas;XBrett A. McGregor;Lalida Rojanathammanee;XKelley R. Puig;K. Puig;XSanjib Karki;Michael R. Nichols;D. Darland;James E. Porter;Colin K. Combs
  • 通讯作者:
    Colin K. Combs

Michael R. Nichols的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael R. Nichols', 18)}}的其他基金

Mechanisms of NLRP3 inflammasome activation
NLRP3炎症小体激活机制
  • 批准号:
    10796165
  • 财政年份:
    2023
  • 资助金额:
    $ 36.31万
  • 项目类别:
Oligomerization State and Function of the NLRP3 Inflammasome
NLRP3 炎症小体的寡聚状态和功能
  • 批准号:
    9099379
  • 财政年份:
    2016
  • 资助金额:
    $ 36.31万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.31万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.31万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了